SOPHiA GENETICS SA
SOPH
87 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Apr 14 8:02 PM | Ross MukenPresident | Sale | 4,442 | $4.77 | $21.2K | 685,232(D) | View → |
| Apr 10, 2026 | Apr 14 8:02 PM | Ross MukenPresident | Sale | 3,687 | $4.69 | $17.3K | 689,674(D) | View → |
| Apr 13, 2026 | Apr 14 8:01 PM | Philippe MenuChief Medical Officer | Sale | 4,400 | $4.76 | $21.0K | 268,596(D) | View → |
| Apr 10, 2026 | Apr 14 8:01 PM | Philippe MenuChief Medical Officer | Sale | 3,725 | $4.68 | $17.4K | 272,996(D) | View → |
| Apr 9, 2026 | Apr 10 8:02 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 1,950 | $4.74 | $9.2K | 3,724,200(D) | View → |
| Apr 8, 2026 | Apr 10 8:02 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 2,800 | $4.84 | $13.6K | 3,726,150(D) | View → |
| Apr 9, 2026 | Apr 10 8:02 PM | Ross MukenPresident | Sale | 1,950 | $4.74 | $9.2K | 693,361(D) | View → |
| Apr 8, 2026 | Apr 10 8:02 PM | Ross MukenPresident | Sale | 2,786 | $4.84 | $13.5K | 695,311(D) | View → |
| Apr 9, 2026 | Apr 10 8:02 PM | Zhenyu XuChief Scientific Officer | Sale | 1,936 | $4.74 | $9.2K | 640,216(D) | View → |
| Apr 8, 2026 | Apr 10 8:02 PM | Zhenyu XuChief Scientific Officer | Sale | 2,800 | $4.84 | $13.5K | 642,152(D) | View → |
| Apr 9, 2026 | Apr 10 8:02 PM | Philippe MenuChief Medical Officer | Sale | 1,931 | $4.74 | $9.2K | 276,721(D) | View → |
| Apr 8, 2026 | Apr 10 8:02 PM | Philippe MenuChief Medical Officer | Sale | 2,800 | $4.84 | $13.5K | 278,652(D) | View → |
| Apr 8, 2026 | Apr 10 8:02 PM | Manuela ValenteChief People Officer | Sale | 3,824 | $4.85 | $18.5K | 215,451(D) | View → |
| Apr 9, 2026 | Apr 10 8:02 PM | Well Daan VanChief Legal Officer | Sale | 1,988 | $4.74 | $9.4K | 348,820(D) | View → |
| Apr 8, 2026 | Apr 10 8:02 PM | Well Daan VanChief Legal Officer | Sale | 2,861 | $4.85 | $13.9K | 350,808(D) | View → |
| Apr 8, 2026 | Apr 10 8:02 PM | George CardozaChief Financial Officer | Sale | 1,403 | $4.85 | $6.8K | 291,458(D) | View → |
| Apr 8, 2026 | Apr 8 8:37 PM | GEORGE CARDOZA | Proposed Sale | 1 | $4.90 | $5 | — | View → |
| Apr 7, 2026 | Apr 8 8:05 PM | Philippe MenuChief Medical Officer | Sale | 2,400 | $4.87 | $11.7K | 281,452(D) | View → |
| Apr 6, 2026 | Apr 8 8:05 PM | Philippe MenuChief Medical Officer | Sale | 2,700 | $4.85 | $13.1K | 283,852(D) | View → |
| Apr 6, 2026 | Apr 8 8:05 PM | Kevin PuylaertChief Sales Officer | Sale | 624 | $4.86 | $3.0K | 148,230(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Apr 3 10:59 AM | Zhenyu XuChief Scientific Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Jurgi CamblongDirector, Chief Executive Officer | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Kevin PuylaertChief Sales Officer | Grant/Award | 82,335 | $5.04 | 82,335(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | George CardozaChief Financial Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Manuela ValenteChief People Officer | Grant/Award | 104,790 | $5.04 | 104,790(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Well Daan VanChief Legal Officer | Grant/Award | 142,216 | $5.04 | 142,216(D) | View → |
← Previous
Page 2 of 2